Systematic analysis of doxorubicin-induced myocardial injury mechanisms using network toxicology and molecular

Feng Jiang1, Zhen Zheng2, Kaitai Liu2

  • 1Department of Cardiovascular Medicine, The Second Hospital of Yinzhou, Ningbo, Zhejiang Province, China.

Medicine
|August 13, 2025
PubMed

Insights

This study identifies key molecular targets like AKT1 and EGFR involved in doxorubicin-induced cardiotoxicity using computational methods. Findings pave the way for strategies to reduce heart damage from this chemotherapy drug.

Area of Science:

  • Pharmacology
  • Computational Biology
  • Toxicology

Background:

  • Doxorubicin (DOX) is a vital chemotherapy agent but causes significant cardiotoxicity.
  • Understanding the molecular mechanisms of DOX-induced myocardial injury is crucial for mitigating its adverse effects.

Purpose of the Study:

  • To systematically investigate the molecular mechanisms of doxorubicin-induced myocardial injury.
  • To identify critical molecular targets for reducing doxorubicin's cardiotoxicity using network toxicology, molecular docking, and molecular dynamics simulations.

Main Methods:

  • Systematic mining of multiple databases for DOX-related targets.
  • Construction and analysis of a protein-protein interaction network using STRING and Cytoscape.
  • Gene Ontology and KEGG pathway enrichment analysis via WebGestalt.
  • Molecular docking and 100 ns molecular dynamics simulations to assess drug-target interactions and complex stability.

Main Results:

  • Identified 5 critical hub genes (AKT1, TP53, EGFR, HIF1A, BCL2) involved in DOX-induced myocardial injury.
  • Functional enrichment highlighted roles in oxidative stress, ROS metabolism, and membrane processes.
  • Molecular docking showed strong binding interactions (-5.2 to -7.8 kcal/mol).
  • Molecular dynamics simulations revealed differential complex stability, with EGFR being the most stable.

Conclusions:

  • This integrated computational approach elucidates DOX-induced myocardial injury mechanisms.
  • Key targets and their binding stability with DOX were identified.
  • Provides a foundation for developing targeted strategies to minimize cardiotoxicity while maintaining therapeutic efficacy.